Page last updated: 2024-11-04

sotalol and Bronze Diabetes

sotalol has been researched along with Bronze Diabetes in 1 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lemery, R1
Brugada, P1
Havenith, M1
Barbour, D1
Roberts, WC1
Wellens, HJ1

Other Studies

1 other study available for sotalol and Bronze Diabetes

ArticleYear
Sudden death in hemochromatosis after closed-chest catheter ablation of the atrioventricular junction.
    The American journal of cardiology, 1988, Apr-15, Volume: 61, Issue:11

    Topics: Atrial Fibrillation; Atrioventricular Node; Death, Sudden; Electric Countershock; Electrocardiograph

1988